- Home
- CCEL vs AIRT Comparison
CCEL vs AIRT Comparison
Compare CCEL & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- AIRT
- Stock Information
- Founded
- CCEL 1989
- AIRT 1980
- Country
- CCEL United States
- AIRT United States
- Employees
- CCEL N/A
- AIRT N/A
- Industry
- CCEL Managed Health Care
- AIRT Air Freight/Delivery Services
- Sector
- CCEL Health Care
- AIRT Consumer Discretionary
- Exchange
- CCEL Nasdaq
- AIRT Nasdaq
- Market Cap
- CCEL 39.9M
- AIRT 53.2M
- IPO Year
- CCEL 1997
- AIRT N/A
- Fundamental
- Price
- CCEL $5.05
- AIRT $21.13
- Analyst Decision
- CCEL Strong Buy
- AIRT
- Analyst Count
- CCEL 1
- AIRT 0
- Target Price
- CCEL $8.50
- AIRT N/A
- AVG Volume (30 Days)
- CCEL 14.8K
- AIRT 2.8K
- Earning Date
- CCEL 07-14-2025
- AIRT 06-27-2025
- Dividend Yield
- CCEL 19.80%
- AIRT N/A
- EPS Growth
- CCEL N/A
- AIRT N/A
- EPS
- CCEL 0.01
- AIRT N/A
- Revenue
- CCEL $32,102,750.00
- AIRT $291,850,000.00
- Revenue This Year
- CCEL $2.49
- AIRT N/A
- Revenue Next Year
- CCEL $0.95
- AIRT N/A
- P/E Ratio
- CCEL $559.31
- AIRT N/A
- Revenue Growth
- CCEL 2.33
- AIRT 1.75
- 52 Week Low
- CCEL $4.75
- AIRT $14.56
- 52 Week High
- CCEL $9.43
- AIRT $30.60
- Technical
- Relative Strength Index (RSI)
- CCEL 46.82
- AIRT 54.46
- Support Level
- CCEL $5.00
- AIRT $18.86
- Resistance Level
- CCEL $6.35
- AIRT $22.50
- Average True Range (ATR)
- CCEL 0.28
- AIRT 1.01
- MACD
- CCEL -0.00
- AIRT -0.09
- Stochastic Oscillator
- CCEL 3.70
- AIRT 42.31
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.